This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The Abu Dhabi Department of Health (DoH) in the UAE has made a declaration of collaboration with Mass General Brigham’s (MGB) International Center for Genetic Disease (iCGD) to advance lifesciences.
GSK has entered a strategic partnership with Wave LifeSciences to progress the discovery and development of oligonucleotide therapies for new genetic targets. The alliance will merge the PRISM oligonucleotide platform of Wave and the capabilities of GSK in genetics and genomics.
From the Human Genome Project to contemporary drug development, collaboration is critical to the lifesciences. It is also an important factor in the success of lifesciences clusters, where a high concentration of pharmaceutical or medical device companies can all be found in one district, city or region.
Canary Wharf’s bid to become a new hub for the lifesciences sector in the UK has been given a boost following the decision by Genomics England to relocate to the development. facility dedicated to a combination of wet lab and office space, revealed in March, intended as a focal point for lifesciences companies in London.
As we step into 2024, the lifesciences continue to evolve at an unprecedented pace, driven by technological innovation, a deeper understanding of human biology and the application of new technologies in areas like drug development and health wearables. These companies are at various stages of research and clinical trials.
The application of whole genome sequencing (WGS) to derive a more complete understanding of cancer has been a central goal of cancer researchers even before the first human genome was decoded in 2003. Ultima Genomics has already partnered with other leading biotech startups.
McLeod received his Doctorate in Pharmacy from the Philadelphia College of Pharmacy and Science and completed his Post-Doctoral Training at St Jude Children’s Research Hospital and the University of Glasgow. Subscribe to the Xtalks LifeScience Podcast to never miss a new episode.
How did you get into lifesciences? Dr Doina Ionescu (DI): After completing my PhD in physics at the University of Southampton, I joined Merck as a research scientist in 1998. DI: Transitioning from being a research scientist to a mergers & acquisitions project manager was not easy. What has your career path been?
27, Vilnius will host the EFIB’2022 event which will bring the European lifescience sector together. In the field of lifesciences, Lithuania is best known for the discovery of gene scissors by Prof. Lab, focused on research and development of novel genome editing tools. Virginijus Šikšnys.
Alongside drugs and therapeutics, data collection and technology enhancements have redefined the traditional healthcare experience, especially within oncology, and genomic profiling has become a significant factor in allowing for personalised care. Tailored oncology.
ERS Genomics and G+FLAS LifeSciences sign CRISPR/Cas9 license agreement ERS Genomics and G+FLAS LifeSciences sign CRISPR/Cas9 license agreement G+FLAS LifeSciences is applying CRISPR technology to develop research tools and reagents DUBLIN & SEOUL–(BUSINESS WIRE)–ERS Genomics Limited, which … Continue reading →
Nashville Biosciences and Illumina Announce Agreement to Establish Preeminent Clinico-Genomic Resource for LifeSciencesResearch & Development Nashville Biosciences and Illumina Announce Agreement to Establish Preeminent Clinico-Genomic Resource for LifeSciencesResearch & Development NASHVILLE, Tenn.–(BUSINESS
One of the more intriguing developments in cancer research in recent years is the growing understanding of clonal hematopoiesis, a phenomenon where blood cells expand from a single clone due to genetic mutations. Clonal hematopoiesis increases in prevalence with age and can precede hematologic malignancies.
BARCELONA/LONDON, 25.05.23: Seqera Labs, the leading provider of secure workflow orchestration software in the lifesciences sector, has partnered with Genomics England, the government-owned company that launched the 100,000 Genomes Project in partnership with the NHS.
The PING Conference 2022 is back in person this year, with opportunities to network face-to-face with people from right across the lifesciences ecosystem. Hear about how the UK is leading the way in what has been described as the ‘Golden Age for LifeSciences Innovation’ and the opportunities arising from this from leading experts.
The power of leveraging clinical data to decipher disease mechanisms and fuel drug discovery has rapidly grown in the era of genomics and personalized medicine. Generation of strong research dataset cohorts must begin with high-quality clinical samples. Partnerships and Establishing Research Cohorts.
The most complete database of protein structures ever assembled, developed with the help of Google’s artificial intelligence unit DeepMind, has been made freely available to researchers around the world. Around a third of the structures are considered to be detailed and precise enough to allow drug design. Demis Hassabis.
Research into single-cell sequencing has been boosted with Single Cell Discoveries and BioTuring joining forces to refine the process. A rapidly growing field of research, single-cell RNA sequencing is vital for those working in areas such as oncology, immunology, and neuroscience.
The answer to the problem, of course, lays in making medical research more effective. However, developments in genomic medicine are making huge strides to improve this situation, and these will also be discussed during the webinar. Far more common than initially thought, rare disease treatments remain far too scarce. About IQVIA.
John Finn, PhD Chief Scientific Officer Tome Biosciences Dr. Finn has over 20 years of experience in the gene therapy space with a focus on genome editing and delivery technologies. Subscribe to the Xtalks LifeScience Podcast to never miss a new episode.
(NASDAQ: ILMN), the global leader in DNA sequencing and array-based technologies, and Sequoia Capital China , a leading investment firm, today announced a collaboration to catalyze the startup ecosystem in China with the launch of the Sequoia Capital China Intelligent Healthcare Genomics Incubator, Powered by Illumina.
Lee Honigberg on the Future of Blood-Based Biomarker Assays GeneDX GeneDX recently integrated AI (Multiscore) into its interpretation platform, improving speed and accuracy in analyzing complex genomic data. 10x Genomics 10x Genomics reported $707 million in 2024 revenue.
27, Vilnius will host the EFIB’2022 event which will bring the European lifescience sector together. In the field of lifesciences, Lithuania is best known for the discovery of gene scissors by Prof. Lab, focused on research and development of novel genome editing tools. Virginijus Šikšnys.
The up-and-coming field of spatial genomics in biology promises to bridge the gap between high plex, high throughput, and high resolution. 70+ spatial Genomics solutions are developed by industry and non-industry players. 70+ spatial Genomics solutions are developed by industry and non-industry players. Concluding Remarks.
Bio-Rad and 10x Genomics Announce Settlement to Resolve Multiple Litigations Bio-Rad and 10x Genomics Announce Settlement to Resolve Multiple Litigations HERCULES, Calif.–(BUSINESS NYSE: BIO and BIOb), a global leader of lifescienceresearch and clinical diagnostic products, … Continue reading →
Data in clinical trials For example, huge amounts of data can be mined from electronic health records (EHRs) and other sources to optimise clinical research, from drug identification to treatment plan design. When it is properly utilised, this information can be used to improve patient outcomes.
Montreal, Canada-based Caprion Biosciences announced last week that the clinical research organization (CRO) will rebrand as CellCarta. The move follows the 2019 merger between Caprion and HistoGeneX , a Belgian histopathology and genomics lab.
I recently had the pleasure of attending the PING Conference 2022 , which had the tagline of ‘The Golden Age for LifeSciences Innovation’. Aspirations for the UK in lifesciences. Faster access for patients for interventions. Data on all aspects, including stratification of patient types.
HumGut comprises a collection of about 30,000 genomes, covering the broad diversity of bacterial genomes found in the human gut. This work is funded by the Norwegian University of LifeSciences (NMBU) and GA with support from the Research Council of Norway through an Industrial PhD program.
Do you possess laboratory skills, an analytical mindset and a penchant for research? A clinical scientist conducts research to help prevent illness and develops techniques to support patient diagnosis and treatment. They will often find themselves working in a healthcare or pharmaceutical field that supports human health research.
Expanding upon the CRISPR-Cas9 gene editing system, researchers at MIT have designed a new technique called PASTE gene editing that can cut out defective genes and replace them with new genes in a safer and more efficient way. The MIT research team turned to a family of enzymes called integrases to meet their goal.
CRISPR is notable for engineering living cells, allowing scientists to edit, turn off, delete, or replace genes in a cell’s genome. It is difficult to control where the viral vectors insert genes in the genome, and it is difficult to manufacture large quantities of clinical-grade viral vectors. From the Bench to Patient Therapeutics.
As data and digital technology become vital to every aspect of lifesciences, the industry is increasingly looking beyond biologists, chemists, and doctors to drive its drug development – and finding that technology has a chief role to play in the future of medicine. on Big data: astronomical or genomical? ,
This is where modern technologies and data-driven medical informatics can bridge gaps in RD research. . The webinar will also cover: How the necessary routine and research data can be collected in registries in a further processable form by patients and healthcare professionals.
And this is where modern technologies and data-driven medical informatics can really bridge the gaps in rare disease research,” said Dr Joanne Hackett, head of Genomic and Precision Medicine at IQVIA, during a recent pharmaphorum webinar. Navigating rare disease research and treatment.
It was found that the gene being delivered through the therapy had integrated into the genomes of six of the seven mice that were administered the highest dose. Although a rare event that occurs at very low frequency, AAV vectors can integrate into genomes through homologous recombination.
Other issues include medical systems that can often be dismissive of women’s health concerns or experiences, and historically less research on women’s health, which together, can lead to late diagnoses or misdiagnoses. Through this, researchers can pinpoint breast cancer cell types and their phenotypic states.
Exact Sciences (Overall Rank 281) Exact Sciences , founded in 1995, is a molecular diagnostics company specializing in early cancer screening and diagnostic tests. Exact Sciences is also investing in its pipeline to develop innovative solutions before, during and after a cancer diagnosis. Thermo Fisher Scientific boasts a $42.86
CancerVar will help researchers standardize and automate clinical interpretations for 13 million somatic mutations from 1,911 cancer census genes. The gene mutations that cause sporadic cancer occur only in the tumor cells and are acquired during an individual’s life, not inherited. What is CancerVar? Why Was CancerVar Developed?
XTALKS WEBINAR: Accelerating Neurodegenerative Clinical Drug Development with AI Live and On-Demand: Wednesday, September 18, 2024, at 11am EDT (4pm BST/UK) Register for this webinar today to gain insights into how AI is playing a crucial role in advancing CNS research related to neurodegenerative clinical drug development.
Rare Disease Day 2024, which falls on February 29 this year, is an opportunity to unite under a common cause: to bring attention to the challenges faced by those living with rare diseases and to push for advancements in research, treatment and policy. The FDA introduced its Orphan Drug Act in 1983.
In recent webinars by Genuity Science, formerly known as WuXi NextCODE, experts from the biotech and pharma industries spoke about leveraging the power of single cell RNA sequencing platforms and solutions in conjunction with machine learning technologies such as AI in cell biology and disease research. Chromium Single Cell Solutions.
So, when a new disease emerges, researchers have a near-impossible task working upstream from symptoms to identify the underlying cause and biological mechanisms causing disease. This problem is compounded when researchers are presented with a complex set of symptoms, with no easily identifiable infectious agent as the cause.
.
Accenture Applied Intelligence announced a new data and analytics approach to manage and derive insights from paediatric acute myeloid leukaemia (AML) genomic data, with the potential to improve precision medicine. And for some people, that treatment worked.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content